riboflavin 5'-phosphate sodium · Glaukos · NDA 219910
Epioxa Hd/Epioxa Kit
Earliest generic entry, as listed
17 Oct 2028
Blocked by exclusivity: NP.
Listed patents · 0 unexpired
No unexpired patents listed.
Exclusivities · 1 unexpired
| NP | new product | 17 Oct 2028 |
Paragraph IV certifications · 0
No Paragraph IV certification listed by FDA for this drug.
The list shows that a generic applicant certified to FDA that a listed patent is invalid or not infringed. It does not show litigation, settlements or launch timing.
Event history
No events yet. The first ingestion only records products entering their 12-month window; changes appear from the next Orange Book update.
Products covered · 1
| NDA · product | Form | Strength | Listed expiry |
|---|---|---|---|
| 219910 · 001 · RLD | solution/drops, ophthalmic | EQ 0.239% BASE/ML;EQ 0.177% BASE/ML | 17 Oct 2028 |